Stock listing

AARD Stock Price, News, Filings & Events — Aardvark Therapeutics, Inc.

Selected listing: AARD · NASDAQ · USD · US

This page tracks Aardvark Therapeutics, Inc.'s AARD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AARD:NASDAQ. AARD:NASDAQ is the stock-level entry point for investors researching Aardvark Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aardvark Therapeutics, Inc. (ticker: AARD) is a public company based in the United States with a market capitalization of approximately $128.24 million. The company is focused on developing innovative therapeutic solutions. Aardvark Therapeutics aims to address unmet medical needs through its research and development efforts.

AARD:NASDAQUSDUSUpdated September 11, 2026
Aardvark Therapeutics, Inc. logo
Ticker
AARD:NASDAQ
Asset type
Stock
Market cap
$112.3M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Aardvark Therapeutics, Inc. AARD:NASDAQ stock context

This page tracks Aardvark Therapeutics, Inc.'s AARD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AARD:NASDAQ. AARD:NASDAQ is the stock-level entry point for investors researching Aardvark Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aardvark Therapeutics, Inc. (ticker: AARD) is a public company based in the United States with a market capitalization of approximately $128.24 million. The company is focused on developing innovative therapeutic solutions. Aardvark Therapeutics aims to address unmet medical needs through its research and development efforts.

Latest news from Aardvark Therapeutics, Inc.

All Aardvark Therapeutics, Inc. news →

Research Aardvark Therapeutics, Inc.

Alternate listings